Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$11,814,246
+$1,386,471 QoQ
Shares Held
46,949
-2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#842
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $78,680,706 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,012 | $25,202,425 | |
| 2 | JNJ |
Johnson & Johnson
|
63,968 | $16,245,952 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
46,949 | $11,814,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,631 | $8,433,583 | |
| 5 | AMGN |
Amgen Inc
|
14,346 | $5,194,973 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
32,954 | $4,163,408 | |
| 7 | PFE |
Pfizer Inc
|
151,478 | $3,647,590 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
54,255 | $3,126,173 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,814,246 | 46,949 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $10,427,775 | 47,946 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $10,980,772 | 48,058 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $19,753,835 | 85,315 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $17,142,378 | 92,352 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $19,591,796 | 93,508 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $16,877,057 | 94,975 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $19,292,413 | 97,693 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,415,797 | 101,538 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $18,936,396 | 103,989 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $17,324,096 | 111,790 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $18,880,386 | 126,663 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $19,947,989 | 148,059 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $23,925,421 | 150,125 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $24,161,503 | 149,505 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $19,776,917 | 147,358 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $22,460,301 | 146,646 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $23,923,383 | 147,575 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $20,254,621 | 149,591 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $16,357,946 | 151,645 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $17,265,346 | 153,279 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $16,684,169 | 154,169 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $17,053,029 | 159,151 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $14,210,426 | 162,238 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $16,101,912 | 164,004 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $11,153,987 | 146,397 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||